Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

NCT05983172 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05983172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05983172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2023
Completion date
July 31, 2026
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia